Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (3): 255-260.doi: 10.3969/j.issn.1000-6621.2021.03.011
• Original Articles • Previous Articles Next Articles
DUAN Hui-juan, CHU Hong-qian, KONG Cheng-cheng, DAI Guang-ming, CAO Ting-ming, SUN Zhao-gang()
Received:
2020-11-02
Online:
2021-03-10
Published:
2021-03-03
Contact:
SUN Zhao-gang
E-mail:sunzg75@163.com
DUAN Hui-juan, CHU Hong-qian, KONG Cheng-cheng, DAI Guang-ming, CAO Ting-ming, SUN Zhao-gang. Evaluation of the effect of skin reaction on 11 Mycobacterium tuberculosis antigens[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 255-260. doi: 10.3969/j.issn.1000-6621.2021.03.011
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.03.011
BCG缺失区 | 缺失该区基因的基因组 | 抗原名称 |
---|---|---|
RD1 | BCG基因组 | 重组结核杆菌融合蛋白(EC)、Rv3872 |
RD2 | 部分BCG中,BCG-Danish、BCG-Prague、BCG-Glaxo、BCG-Connaught、BCG-Phipps、BCG-Tice和BCG-Pasteur基因组 | MPT64、Rv1985c |
RD4 | BCG和牛分枝杆菌基因组 | Rv0222 |
RD5 | BCG和牛分枝杆菌基因组 | Rv3117、Rv3120 |
RD7 | BCG和牛分枝杆菌基因组 | Rv2346c |
RD9 | 非洲分枝杆菌、牛分枝杆菌和BCG基因组 | Rv3619c |
RD11 | BCG基因组 | Rv3425 |
MTB休眠相关抗原a | - | Rv1738、Rv2626c |
抗原名称 | 表达情况 | 浓度(mg/ml) | 缓冲液 |
---|---|---|---|
重组结核杆菌融合蛋白(EC) | 包涵体 | 1.3 | 磷酸盐缓冲液 |
MPT64 | 包涵体 | 0.8 | 聚苯稀酰胺凝胶电泳缓冲液 |
Rv1985c | 包涵体 | 1.4 | 聚苯稀酰胺凝胶电泳缓冲液 |
Rv0222 | 包涵体 | 1.4 | 20mmol/L三羟甲基氨基甲烷(pH 8.0),0.9%氯化钠 |
Rv3117 | 可溶 | 2.0 | 磷酸盐缓冲液 |
Rv3872 | 可溶 | 1.1 | 磷酸盐缓冲液 |
Rv1738 | 可溶 | 1.5 | 磷酸盐缓冲液 |
Rv3425 | 包涵体 | 1.0 | 磷酸盐缓冲液 |
Rv2626c | 可溶 | 2.0 | 磷酸盐缓冲液 |
Rv3619c | 包涵体 | 1.8 | 磷酸盐缓冲液 |
Rv3120 | 包涵体 | 1.1 | 磷酸盐缓冲液 |
Rv2346c | 包涵体 | 1.1 | 磷酸盐缓冲液 |
抗原 | 皮肤试验反应24h | 皮肤试验反应48h | Z值 | P值 |
---|---|---|---|---|
TB-PPD(5IU) | 9.00(7.00,11.00) | 6.50(5.50,8.25) | -2.494 | 0.013 |
Rv3872 | 3.00(0.00,5.00) | 0.00(0.00,0.00) | -2.023 | 0.043 |
MPT64 | 3.00(0.00,6.00) | 0.00(0.00,5.00) | -1.069 | 0.285 |
Rv1985c | 3.50(0.00,6.50) | 0.00(0.00,5.50) | -1.483 | 0.138 |
Rv0222 | 3.00(0.00,5.00) | 0.00(0.00,5.00) | -1.826 | 0.068 |
Rv1738 | 0.00(0.00,3.50) | 0.00(0.00,0.00) | -1.604 | 0.109 |
Rv3117 | 5.00(0.00,7.00) | 0.00(0.00,4.25) | -2.201 | 0.028 |
Rv3120 | 8.50(6.25,9.25) | 5.00(0.00,5.50) | -2.673 | 0.008 |
Rv2346c | 4.00(1.50,6.75) | 2.50(0.00,3.75) | -2.207 | 0.027 |
Rv3619c | 6.50(5.50,8.25) | 3.50(1.50,4.75) | -2.670 | 0.008 |
Rv3425 | 5.00(4.00,6.25) | 0.00(0.00,2.75) | -2.684 | 0.007 |
Rv2626c | 3.50(1.25,6.25) | 0.00(0.00,2.25) | -2.371 | 0.018 |
抗原 | 皮肤试验反应24h | 皮肤试验反应48h | Z值 | P值 |
---|---|---|---|---|
TB-PPD(5IU) | 9.00(7.00,11.00) | 6.50(5.50,8.25) | -2.494 | 0.013 |
重组结核杆菌融合蛋白(EC) | 13.00(12.75,14.25) | 9.00(8.00,9.75) | -2.677 | 0.007 |
Rv3872 | 0.00(0.00,3.00) | 0.00(0.00,0.00) | -1.604 | 0.109 |
MPT64 | 9.50(8.50,12.50) | 8.50(5.50,9.50) | -2.207 | 0.027 |
Rv1985c | 0.00(0.00,0.00) | 0.00(0.00,0.00) | 0.000 | 1.000 |
Rv0222 | 0.00(0.00,2.50) | 0.00(0.00,0.00) | -1.633 | 0.102 |
Rv1738 | 0.00(0.00,0.00) | 0.00(0.00,0.00) | 0.000 | 1.000 |
Rv3117 | 3.50(3.00,5.00) | 0.00(0.00,0.00) | -2.214 | 0.027 |
Rv3120 | 5.50(5.00,6.50) | 0.00(0.00,0.00) | -2.226 | 0.026 |
Rv2346c | 3.50(0.00,5.00) | 0.00(0.00,0.00) | -2.032 | 0.042 |
Rv3619c | 3.50(0.00,4.00) | 0.00(0.00,0.00) | -1.841 | 0.066 |
Rv3425 | 0.00(0.00,3.50) | 0.00(0.00,0.00) | -1.342 | 0.180 |
Rv2626c | 0.00(0.00,3.00) | 0.00(0.00,0.00) | -1.342 | 0.180 |
[1] |
Ruhwald M, Aggerbeck H, Gallardo RV, et al. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon gamma release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Lancet Respir Med, 2017,5(4):259-268. doi: 10.1016/S2213-2600(16)30436-2.
doi: 10.1016/S2213-2600(16)30436-2 URL pmid: 28159608 |
[2] |
Ruhwald M, Andersen PL. New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets. Future Microbiol, 2016,11:1101-1104. doi: 10.2217/fmb-2016-0131.
doi: 10.2217/fmb-2016-0131 URL pmid: 27545599 |
[3] | 中国防痨协会, 中国防痨协会学校与儿童结核病防治专业分会, 《中国防痨杂志》编辑委员会. 重组结核杆菌融合蛋白(EC)临床应用专家共识. 中国防痨杂志, 2020,42(08):761-768. doi: 10.3969/j.issn.1000-6621.2020.08.001. |
[4] |
Chen J, Wang S, Zhang Y, et al. Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls. BMC Infect Dis, 2010,10:273. doi: 10.1186/1471-2334-10-273.
doi: 10.1186/1471-2334-10-273 URL pmid: 20849593 |
[5] |
Zhang MM, Zhao JW, Sun ZQ, et al. Identification of RD5-encoded Mycobacterium tuberculosis proteins as B-cell antigens used for serodiagnosis of tuberculosis. Clin Dev Immunol, 2012,2012:738043. doi: 10.1155/2012/738043.
doi: 10.1155/2012/738043 URL pmid: 22701501 |
[6] |
Fu R, Wang C, Shi C, et al. An improved whole-blood gamma interferon assay based on the CFP21-MPT64 fusion protein. Clin Vaccine Immunol, 2009,16(5):686-691. doi: 10.1128/CVI.00486-08.
doi: 10.1128/CVI.00486-08 URL pmid: 19279170 |
[7] |
Rosenkrands I, Aagaard C, Weldingh K, et al. Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis. Tuberculosis (Edinb), 2008,88(4):335-343. doi: 10.1016/j.tube.2007.12.001.
doi: 10.1016/j.tube.2007.12.001 URL |
[8] | 都伟欣, 卢锦标, 王国治, 等. 4种结核分枝杆菌皮肤变态反应原的动物试验. 中国生物制品学杂志, 2018,31(7):741-743, 747. doi: 10.13200/j.cnki.cjb.002231. |
[9] | 张凯, 沈小兵, 陶立峰, 等. 重组结核杆菌融合蛋白(EC)产品质量标准的建立. 中国防痨杂志, 2020,42(08):814-820. doi: 10.3969/j.issn.1000-6621.2020.08.007. |
[10] |
Hoff ST, Peter JG, Theron G, et al. Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection. Eur Respir J, 2016,47(3):919-928. doi: 10.1183/13993003.01464-2015.
doi: 10.1183/13993003.01464-2015 URL pmid: 26677940 |
[11] |
Flores-Villalva S, Suárez-Güemes F, Espitia C, et al. Specificity of the tuberculin skin test is modified by use of a protein cocktail containing ESAT-6 and CFP-10 in cattle naturally infected with Mycobacterium bovis. Clin Vaccine Immunol, 2012,19(5):797-803. doi: 10.1128/CVI.05668-11.
doi: 10.1128/CVI.05668-11 URL |
[12] |
Hur YG, Chung WY, Kim A, et al. Host immune responses to antigens derived from a predominant strain of Mycobacterium tuberculosis. J Infect, 2016,73(1):54-62. doi: 10.1016/j.jinf.2016.04.032.
doi: 10.1016/j.jinf.2016.04.032 URL pmid: 27155519 |
[13] |
Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol, 2009,27:393-422. doi: 10.1146/annurev.immunol.021908.132703.
doi: 10.1146/annurev.immunol.021908.132703 URL pmid: 19302046 |
[14] | Dannenberg AM Jr, Collins FM. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (Edinb), 2001,81(3):229-242. doi: 10.1054/tube.2001.0287. |
[15] | 都伟欣, 韦芬, 卢锦标, 等. 冻干重组结核杆菌融合蛋白(EC)原液效力评价用国家参考品的初步建立. 中国防痨杂志, 2020,42(8):826-831. doi: 10.3969/j.issn.1000-6621.2020.08.009 |
[16] |
Nicolo C, Sali M, Di Sante G, et al. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis. J Immunol, 2010,184(1):222-235. doi: 10.4049/jimmunol.0804263.
doi: 10.4049/jimmunol.0804263 URL pmid: 19949067 |
[17] | 柏银兰, 薛莹, 王丽梅, 等. 结核分枝杆菌MPT64抗原DNA疫苗在小鼠体内诱导的免疫应答. 中国人兽共患病学报, 2009,25(5):418-421, 494. doi: 10.3969/j.issn.1002-2694.2009.05.005. |
[18] |
Mahmood A, Srivastava S, Tripathi S, et al. Molecular characterization of secretory proteins Rv3619c and Rv3620c from Mycobacterium tuberculosis H37Rv. FEBS J, 2011,278(2):341-353. doi: 10.1111/j.1742-4658.2010.07958.x.
doi: 10.1111/j.1742-4658.2010.07958.x URL pmid: 21134129 |
[19] |
Hanif SN, Al-Attiyah R, Mustafa AS. Species-specific antigenic Mycobacterium tuberculosis proteins tested by delayed-type hypersensitivity response. Int J Tuberc Lung Dis, 2010,14(4):489-494.
URL pmid: 20202308 |
[20] | Safar HA, Mustafa AS, Amoudy HA, et al. The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins. PLoS One, 2020,15(2):e228381. doi: 10.1371/journal.pone.0228381. |
[21] |
Schuck SD, Mueller H, Kunitz F, et al. Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection. PLoS One, 2009,4(5):e5590. doi: 10.1371/journal.pone.0005590.
doi: 10.1371/journal.pone.0005590 URL pmid: 19440342 |
[22] |
Shi SD, Hsueh PR, Yang PC, et al. Use of DosR Dormancy Antigens from Mycobacterium tuberculosis for Serodiagnosis of Active and Latent Tuberculosis. ACS Infect Dis, 2020,6(2):272-280. doi: 10.1021/acsinfecdis.9b00329.
doi: 10.1021/acsinfecdis.9b00329 URL pmid: 31815418 |
[23] |
Abubakar I, Jackson C, Rangaka MX. C-Tb: a latent tuberculosis skin test for the 21st century. Lancet Respir Med, 2017,5(4):236-237. doi: 10.1016/S2213-2600(17)30012-7.
doi: 10.1016/S2213-2600(17)30012-7 URL pmid: 28159607 |
[24] |
van Pinxteren LA, Ravn P, Agger EM, et al. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol, 2000,7(2):155-160. doi: 10.1128/cdli.7.2.155-160.2000.
doi: 10.1128/cdli.7.2.155-160.2000 URL pmid: 10702486 |
[1] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[2] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[3] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[4] | Huang Misun, Wu Yaning, Li Guilian, Liu Haican. Research advances of Mycobacterium tuberculosis enrichment technology [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373. |
[5] | Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163. |
[6] | Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan. Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180. |
[7] | Liu Ruihua, Sarina , Wang Furong. Interaction between lung cancer and tuberculosis in disease development and progression [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111. |
[8] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
[9] | Lu Hailin, Wang Wenfei, Tao Wenhui, Lin Peicong, Chen Xinchun, Deng Guofang, Xie Shuixiang. Oleic acid upregulates the expression of perilipin 2 enhancing macrophage clearance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 72-76. |
[10] | Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei. Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062. |
[11] | Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan. Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068. |
[12] | Palidanguli Abudureheman, Wang Senlu, Gulina Badeerhan, Wang Le, Zulikatiayi Abudula, Wang Xinqi, Maiwulajiang Yimamu, Wang Xijiang. Distribution of Mycobacterium tuberculosis genotypes in Kashgar region and their association with clinical characteristics of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1077-1082. |
[13] | Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei. Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097. |
[14] | Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong. Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896. |
[15] | Xu Chunhua, Zhu Shiyu, Hu Yi, Yi Kehua, Song Canlei, Wang Zichun, Wu Yong, Wang Qing, Yang Qianru, Shen Xin. Analysis of screening effect of recombinant Mycobacterium tuberculosis fusion protein in screening Mycobacterium tuberculosis infection in close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 897-902. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||